The present review aimed to compile up to date and comprehensive information of Plumbago zeylanica with special emphasis on its phytochemistry, various scientifically documented pharmacological activities, traditional and folk medicine uses. Traditional system of medicinal consists of large number of plants with various medicinal and pharmacological uses and hence represents a priceless tank of new bioactive molecules. P. zeylanica is one amongst these, found all over the world. In this review, we have attempted to highlight the work carried out on P. zeylanica. It is commonly known as 'Chitraka', and has been recognized in different traditional system of medicines for the treatment of various diseases of human beings in the form of paste and powder. Plant mainly contains naphthoquinones and steroidal compounds. Different parts of this plant are traditionally claimed to be used for the treatment of ailments including anti-fungal, anti-tumor, disease of heart, rheumatic pains, liver diseases, fever, diabetes, and kidney disease to list of few.
INTRODUCTION
The Plumbago zeylanica is commonly known as Ceylon leadwort, Chita, Chitra and Chitramoolam. P. zeylanica Linn (Plumbaginaceae) is perennial, sub-scandant shrub one of the common plants used in Indian traditional system of medicine. The family Plumbaginaceae consists of 10 genera and 280 species. The genus Plumbago includes 3 species, namely Plumbago indica (P. rosea) Plumbago capensis and Plumbago zeylanica, which are distributed in several parts of India.-Among these species, P. zeylanica grows all districts of plains in Andhra Pradesh, Karnataka, Maharashtra etc. common, wild or in cultivation due to its more therapeutic uses (Chetty et al., 2006) .
The root is used as laxative, expectorant, astringent, abortifacient, and in dysentery (Anonymous, 1989; Bhattacharjee, 1998) . Tincture of root bark is used as antiperiodic. The leaves are used as aphrodisiac and in scabies. Its roots are used in traditional system of medicine to cure various ailments like body pain, headache, fever and inflammation (Mittal et al., 2010) . P. zeylanica roots were reported to possess antioxidant, hypolipidemic, with semi woody stems and numerous branches. Its leaves are simply alternate, ovate, narrowed into petiole, oblong-lanceolate and acute. Its flowers are borne in spikes, wheras the rachis of the spike is pubescent or glandular ( Figure 1 ). The Corolla white tube is long and slender. The roots are cylindrical and are irregularly bent having transverse shallow fissures at bents (Figure 1 ). Its fruits are oblong and its capsules are enclosed by persistent viscid calyx (Bhattacharjee, 1998; Chen et al., 2011) .
Medicinal properties
Plant pacifies vitiated vata, kapha, diarrhea, inflammation, fever, nervous palsy, hemorrhoids, skin diseases, irritable bowel disease, epilepsy, ammenorrhoea and anemia. The roots are used as laxative, expectorant, astringent, abortifacient, and in dysentery, cirrhosis, arthritsetc (Table 1) (Bhattacharjee, 1998; Nadakarni and Nadakarni, 1999) .
Phytochemistry
Earlier chemical examination of this plant revealed that the root contains plumbagin, 3-chloroplumbagin, 2,3-biplumbagin, 6,6-biplumbagin, zeylinone, isozeylinone, chitranone (3, 3'-biplumbagin) , droserone, plumbagic acid, plumbazeylanone, glucose, fructose, enzymes as protease and invertase. The leaves and stem contains little or no plumbagin. The aerial parts contain naphthoquinones, sitosterol, lupeol, lupenylacetate, hentriacontane, and amino acids. Plant contains naphthaquinones (Figure 2a ), plumbagin (Figure 2b) , chloroplumbagin, droserone, zeylinone (Figure 2c ), isozeylinone, plumbagic acid, plumba-zeylanone, naphthelenone, isonaphthelenone, isoshinanolone (Anonymous, 1989; Chen et al., 2011; Kumar et al., 2009) . Aspartic acid, tryptophan, tyrosine, threonine, alanine, histidine, glycine, methionine, hydroxyproline, were isolated from the aerial parts (Elizabeth, 2002) . et al. (2008) developed and validated a reverse phase HPLC method with UV detection to quantify plumbagin, the bioactive marker of the roots of P. indica and P. zeylanica. A quantitative high performance thin layer chromatography (HPTLC) method was also developed using hexane: ethyl acetate (8:2) as the mobile phase. Kishore et al. (2010) characterized difuranonaphthoquinones from P. zeylanica roots by spectral analysis (UV, IR, 1D and 2D NMR and MS) and compound identified as naphthoquinones, lapachol, plumbagin, 2-isopropenyl-9-methoxy-1,8-di-oxa-di cyclopenta(b,g) naphthalene-4,10-dione, 9-hydroxy-2-isopropenyl-1,8-dioxa-dicyclopenta (b,g)naphthalene-4,10-dione, 2-(1-hydroxy-1-methyl-ethyl)-9-methoxy-1,8-dioxa-dicyclopenta(b,g)naphthalene-4,10-dione and 5,7 -dihydroxy-8-methoxy-2-methyl-1,4-naphthoquinone were isolated from roots of P. zeylanica.
Analytical methods

Sudhakar
In another study, Okamoto et al. (2001) utilized a method for a biomimetic synthesis of the binaphthoquinone, 3,3′-biplumbagin, isolated from P. zeylanica. The arylaryl coupling reaction of 1-naphthol with SnCl 4 for 2,2′-binaphthol synthesis and its application to the biomimetic synthesis of binaphthoquinone was isolated from P. zeylanica. A simple method for the direct synthesis of 2,2′-binaphthols was developed, utilizing aryl-aryl coupling reaction via electron donor-acceptor complexes of 1-naphthols with SnCl 4 . Hsieh et al. (2006) performed measurement and pharmacokinetic study of plumbagin in a conscious freely The decoction prepared out of the root bark churnam is taken orally (30 to 60 ml) twice in day for about 1 to 2 weeks. In children the dosage should be limited to 5 to 10 ml in divided doses.
3
Hypercholostremia root
The fine powder of the root is taken orally (2 to 5 g) with honey twice a day for a period of 3 months moving rat using liquid chromatography/tandem mass spectrometry. Plumbagin, an herbal ingredient, was isolated from P. zeylanica. Recovery of plumbagin from the rat plasma was about 80%. Xu and Lu (2010) investigated plumbagin induces rosmediated apoptosis in human promyelocytic leukemia cells in vivo-plumbagin, a naphtoquinone from the roots of P. zeylanica is known to possess anticancer and antibacterial activity. The results showed that i.p. injection of plumbagin (2 mg/kg body weight) daily for 3 weeks resulted in a 64.49% reduction of tumor volume compared with the control. These results indicate that plumbagin has potential as a novel therapeutic agent for myeloid leukemia.
Advancement in pharmacological activities
In another study, Yang et al. (2010) reported that plumbagin activates erk1/2 and akt via superoxide, src and pi3-kinase in 3t3-l1 cells. Plumbagin, derived from the plant P. zeylanica, has been shown to chronically activate ERK1/2 and inhibit Akt activity in cancer cells. These results suggest that plumbagin activates NAD(P)H oxidase, Src, and PI3K, and that the activated PI3K or PDK1 subsequently stimulate Akt and Ras-Raf-MEK1/2-ERK1/2 in 3T3-L1 cells. studied potential genotoxicity of plant extracts used in Ethiopian traditional medicine. In the present study, hydroalcoholic extracts of Glinus lotoides, P. zeylanica, Rumex steudelii and Thymus schimperi were evaluated for their DNA damaging effects using the comet assay. In the absence of S9, all extracts were found to induce significant DNA damage without affecting the cell viability. T. schimperi and R. steudelii were the most potent DNA-damaging extracts, and G. lotoides and P. zeylanica the least potent. carried out a study to elucidate the potential genotoxicity and antigenotoxicity of plumbagin in mouse lymphoma L5178Y cells, using the comet assay. Without affecting the cell viability, plumbagin itself was found to induce significant DNA damage at concentrations as low as 0.25 ng/ml. When the cells were exposed to non-DNA damaging concentrations of plumbagin, together with NQNO (known to interact with DNA in many different ways) or catechol (known to induce oxidative DNA damage), plumbagin was found to significantly reduce the catechol-induced DNA damage, but to be without protective effect against the NQNO-induced damage.
Genotoxicity
In another study, investigated the effect of plumbagin on the growth of human pancreatic carcinoma cells and its possible underlying mechanisms.
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Liu's staining and transmission electron microscopy demonstrated morphological changes resembling apoptosis in Panc-1 cells treated with plumbagin. Plumbagin may induce apoptosis in human pancreatic cancer cells primarily through the mitochondria-related pathway followed by both caspase-dependent and caspase-independent cascades. It indicates that plumbagin can be potentially developed as a novel therapeutic agent against pancreatic cancer.
Chen et al. (2009) (2). The in vitro cytotoxicity of PLN, 1 and 2 against seven human tumour cell lines was assayed. The binding properties of PLN, 1 and 2 to DNA were investigated through UV-vis, fluorescence, CD spectra, and gel mobility shift assay, which indicated that 1 and 2 were non-covalent binding and mainly intercalated the neighboring base pairs of DNA. PLN, 1 and 2 exhibit inhibition activity to topoisomerase I (TOPO I), but 1 and 2 were more effective than PLN. Nazeem et al. (2009) investigated the copper-mediated anticancer mechanism of plumbagin in human cancer cells using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt assay for cell growth inhibition, histone/DNA ELISA, homogeneous caspase-3/7 assay for apoptosis as well as alkaline comet assay for DNA single-strand breaks detection; in this report, authors confirm that plumbagin causes effective cell growth inhibition, induces apoptosis and generates single-strand breaks in cancer cells. Incubation of cancer cells with scavengers of ROS and neocuproine inhibited the cytotoxic action of plumbagin proving that generation of ROS and Cu(I) are the critical mediators in plumbagin-induced cell growth inhibition. Powolny and Shingh (2008) investigated the mechanism of human prostate cancer cell growth inhibition by plumbagin, a constituent of the widely used medicinal herb P. zeylanica. Plumbagin treatment decreased viability of human prostate cancer cells (PC-3, LNCaP, and C4-2) irrespective of their androgen responsiveness or p53 status. The present study points towards an important role of ROS in plumbagin-induced apoptosis in human prostate cancer cells. Lin et al. (2003) carried out cytotoxic naphthoquinones and plumbagic acid glucosides from P. zeylanica. Two plumbagic acid glucosides, 30-O-b-glucopyranosyl plumbagic acid and 30-O-b-glucopyranosyl plumbagic acid methylester along with five naphthoquinones, and five coumarins were isolated from the roots of P. zeylanica. Cytotoxicity of these compounds to various tumor cells lines was evaluated, and plumbagin significantly suppressed growth of Raji, Calu-1, HeLa, and Wish tumor cell lines. ) demonstrated for the ethyl acetate, followed, in ascending order, by the acetone and ethanol. Jetty et al. (2010) isolated, separated and evaluated the antimicrobial properties of compounds such as neoisoshinanolone and 1-epineo-isoshinanolone from the roots of P. zeylanica. 1-epineo-isoshinanolone is more active with a MIC of 12.5 to 25 g/ml, whereas neoisoshinanolone has recorded a MIC of 50 to 100 g/ml. The activities are compared with plumbagin (0.78 to 3.13 /ml) and standards streptomycin for bacteria and nystatin for fungi. The root extract of P. zeylanica possesses good antimicrobial activity, which suggests its therapeutic use in the Ayurvedic system of medicine to cure skin diseases. Iqbal and Aqil (2007) studied in-vitro efficacy of bioactive extracts (alcoholic crude extracts and some fractions) of 15 medicinal plants against extended spectrum β-lactamases (ESβL) producing multidrugresistant enteric bacteria. P. zeylanica demonstrated relatively high activity as compared to other plant extracts.
Aquil and ahmad (2007) screened 66 ethanolic plant extracts against nine different bacteria. The highest activity against all groups of bacteria was found in P. zeylanica. In addition, these extracts showed synergistic interaction with tetracycline, chloramphenicol and ciprofloxacin against S. aureus and/or E. coli. Six plants, P. zeylanica, H. indicus, A. calamus, P. granatum, H. antidysenterica and D. regia , were further subjected to fractionation-based study. Gram-positive and Gramnegative MDR bacteria are almost equally sensitive to these extracts/fractions, indicating their broad-spectrum nature.
The Aquil and ahmad (2007) Lemma et al. (2002) studied anti-bacterial activity of P. zeylanica roots on some pneumonia causing pathogens. The anti bacterial activity of polar (aqueous) and nonpolar (pet. Ether) extracts was prepared from the roots of P. zeylanica. Minimum inhibitory concentration value of this particular compound showed comparative activity resembling the commonly used broad spectrum antibiotic, tetracycline. Patil et al. (2011) tested extracts of P. zeylanica and C. nocturnum for larvicidal activity against second, third, and fourth instar larvae of Aedes aegypti. The LC (50) values of all the extracts in different solvents of both the plants were less than 50 ppm (15.40 to 38.50 ppm) against all tested larval instars. Plant extracts also affected the life cycle of A. aegypti by inhibition of pupal development and adult emergence with increasing concentrations. The larvicidal stability of the extracts at five constant temperatures (19, 22, 25, 28 and 31°C) evaluated against fourth instar larvae revealed that toxicity of both plant extracts increases with increase in temperature. Patil et al. (2010) for mosquito larvicidal activity. The crude extracts exhibiting the highest larvicidal activity against An. gambiae were hexane and chloroform extracts from P. zeylanica showed LC 50 6.4 and 6.7 g/ml respectively. Neubert et al. (2006) studied antiviral activities of some Ethiopian medicinal plants used for the treatment of dermatological disorders. In this study, the antiviral activities of the 80% methanolic extracts of Acokanthera schimperi, Euphorbiae schimperi, Inula confertiflora, Mutinus elegans, and P. zeylanica plants have been examined against cox-sackievirus B3 (CVB3), influenza A virus and herpes simplex virus type1 Kupka (HSV-1) using cytopathic effect (CPE) inhibitory assays in HeLa, MDCK, and GMK cells, respective lym CVB3 was inhibited by the extracts of P. zeylanica and HSV-1 by I. confertiflora. Sathya et al. (2010) studied 3β-Hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from P. zeylanica inhibits the proliferation and migration of MDA-MB-231 cells. In this study, the anti-invasive activities of P. zeylanica methanol extract (PME) and pure compound 3β-hydroxylup-20(29)-ene-27,28-dioic acid (PZP) isolated from it are investigated in vitro. PME and PZP were noted to have the ability to induce apoptosis as assessed by flow cytometry. Obtained data provide the molecular basis of the anti-proliferative and anti-metastatic effects of PME and PZP. Sakamoto et al. (2008) developed an enzyme-linked immunosorbent assay (ELISA) using highly-specific monoclonal antibodies against plumbagin. The prepared monoclonal antibody against plumbagin which is secreted from established hybridoma cell line 3A3 (MAb 3A3) has been proven to have highly-specific to plumbagin resulting from cross-reactivities test. The range for calibration of plumbagin by ELISA was 0.2-25 microg mL(-1). Based on validation analysis, this analytical method by ELISA is a precise, accurate, and sensitive method for the determination of plumbagin in plant.
Larvicidal activity
Antiviral activities
Anti-invasive activity
Immunomodulatory agent
Checker et al. (2009) described novel immunomodulatory effects of plumbagin. Plumbagin inhibited T cell proliferation in response to polyclonal mitogen Concanavalin A (Con A) by blocking cell cycle progression. Immunosuppressive effects of plumbagin on cytokine levels were seen in vivo. Plumbagin completely inhibited Con A induced I kB-alpha degradation and NFkB activation. Further, plumbagin prevented graft versus host disease-induced mortality in mice. Sakamoto et al. (2010) carried out a study on singlechain variable fragment (scFv) antibody, fusion of the variable regions of the heavy chain and light chain of immunoglobulin against plumbagin (PL-scFv). The recombinant purified PL-scFv expressed in Sf9 insect cells was found to be different from that expressed in E. coli and parental MAb 3A3, although the detectable level (0.2 to25 μg/ml) was the same in ELISA using each antibody. Even more interestingly, the characteristics of PL-scFv, which have wide cross-reactivity against 1,4-napththoquinone, suggest its potential use as a tool for In another study, Kamal and Rao (1995) studied modulatory effect of plumbagin on macrophage functions in balb/c mice. The data indicate that plumbagin augments the macrophage bactericidal activity by potentiating the oxyradical release at low concentration whereas at the higher concentration it has inhibitory activity. Kofi et al. (2009) carried out acaricidal effects of extracts and compounds derived from P. zeylanica roots against different stages of Amblyomma variegatum. The results indicated that the naphthoquinone plumbagin possesses acaricidal properties thus giving scientific justification for the folkloric use of the plant in animal husbandry. Akintonwa et al. (2009) carried out a research to determine the mutagenic potentials of Morinda lucida (root), Acalypha indica (leaf), Tetrapleura tetraptera (fruit), P. zeylanica (root), Xylopia aethiopica (fruit), Nitzschia laevis (leaf), Aciduliprofundum boonei (bark), Enantia chlorantha (bark), and Rauvolfia vomitoria (root) using the Allium cepa model and the modified Ames assay. The modified Ames test showed an alteration in the biochemical characteristics of E. coli (0157:H7) for all plants except R. vomitoria and P. zeylanica. Aqil et al. (2008) tested methanolic extracts of Acorus calamus (rhizome), Hemidesmus indicus (stem), H. antidysenterica (bark) and P. zeylanica (root), for their antimutagenic potential. These extracts, at tested concentrations, showed no sign of mutagenicity to Salmonella typhimurium tester strains. At a dose of 100 µg/plate, the extracts exhibited the inhibition of His+ revertants from 18.51 to 82.66% against direct acting mutagens, methyl methanesulphonate (MMS) and sodium azide (NaN 3 ) induced mutagenicity in Salmonella tester strains TA 97a, TA 100, TA 102 and TA 104. The overall antimutagenic potential of the aforementioned four extracts was found to be in order of A. calamus > H. indicus > H. antidysenterica > P. zeylanica. Simonsen et al. (2001) carried out in-vitro screening of Indian medicinal plants for antiplasmodial properties against Plasmodium falciparum. Of 80 analyzed ethanol extracts, from 47 species, significant effects were found for 31 of the extracts one of that was P. zeylanica.
Acaricidal properties
Mutagenic screening
Antiplasmodial activity
Anticonvulsant activity
Vishnukanta and Rana (2010) carried out a study on pharmacological and clinical therapeutical uses of Ayurvedic medicinal plants, one of which was P. zeylanica. Leaf extract of this plant were evaluated for anticonvulsant activity using PTZ induced convulsion and maximum electro shocked induced convulsion. It was found that extract has no anticonvulsant activity. Zahin et al. (2009) carried out in vitro antioxidant activity and total phenolic content of methanolic extracts of P. zeylanica (root), A. calamus (rhizome), H. indicus (stem) and H. antidysenterica (bark). The order of antioxidant potential according to FTC assay was found to be highest in P. zeylanica. Natarajan et al. (2006) carried out antioxidant activity of a salt-spice-herbal mixture against frees radical induction. A combination of spices (P. nigrum, P. longum and Z. officinale), herbs (C. rotundus and P. zeylanica) and salts make up Amrita Bindu. It was interesting to note that rats with Amrita Bindu pretreatment showed significantly lower levels of free radicals, lipid peroxidation and protein carbonyls along with significantly higher levels of antioxidants when compared with rats without A. Bindu pretreatment on PHZ administration. These results reveal that A. Bindu, a salt-spice-herbal mixture exerts a promising antioxidant potential against free radical induced oxidative damage.
Antioxidant activity
Hepatoprotective activity
Rajesh et al. (2009) conducted a study to evaluate the hepatoprotective activity of methanolic extract of aerial parts of P. zeylanica in CCl 4 -induced hepatotoxicity in wistar rats. The extract of aerial parts of-P. zeylanica have shown very significant hepatoprotection against CCl 4 -induced hepatotoxicity in wistar rats by reducing serum total bilirubin, SGPT, SGOT and ALP levels. Histopathological studies also confirmed the hepatoprotective nature of the extract. Edwin et al. (2009) evaluated the antifertility properties of extracts of leaves of P. zeylanica. The effects of petroleum ether, chloroform, acetone, ethanol and aqueous extracts of the leaves of P. zeylanica on the estrous cycle of rats were studied at two dose levels, namely, 200 and 400 mg/kg. The acetone and ethanol extracts were most effective in interrupting the estrous cycle of the rats (p < 0.05). The animals exhibited a prolonged diestrous stage of the estrous cycle corresponding to a temporary inhibition of ovulation. The antiovulatory activity was reversible on discontinuation of treatment. Both extracts showed significant oestrogenic and anti-oestrogenic activity (p < 0.05). Teshome et al. (2008) carried out toxicity studies on dermal application of plant extract of P. zeylanica used in Ethiopian traditional medicine. Repeated dose toxicity test was associated with increased relative testis weight (P < 0.05) as well as higher values for blood urea nitrogen and K + (P < 0.05) in both sexes with the highest dose (1000 mg/kg) group, although histopathological analyses failed to lend support to these observations. Taken together, the dermatotoxicity test results from this study suggest that P. zeylanica toxic effects might be limited to effects like moderate irritation. Dang et al. (2011) conducted experimental study to evaluate anti-inflammatory activity of Phyllanthus emblica, P. zeylanica and C. rotundus in acute models of inflammation, namely carrageenan induced rat paw edema and acetic acid induced peritonitis in mice. In carrageenan induced paw edema, P. emblica, P. zeylanica and C. rotundus showed a trend to reduce the edema while the combination of P. emblica + P. zeylanica (PI: 20.64%) showed results comparable to aspirin (23.74%). Whereas in a model of acetic acid induced peritonitis, all the plant drugs, that is, P. emblica, P. zeylanica, C. rotundus and a combination of P. emblica + P. zeylanica showed a significant decrease in the protein content of the peritoneal exudates compared with the disease control group (p < 0.05). Sheeja et al. (2010) carried out the anti-inflammatory and antinociceptive activities of various leaf extracts of P. zeylanica (petroleum ether, chloroform, acetone, ethanol, and aqueous) using in vivo experimental models at two dose levels (200 and 400 mg/kg, p.o.). The acetone extract significantly (p < 0.01) reduced inflammation in the carrageenan induced rats when compared to the control group. As for the analgesia effect, the acetone and petroleum ether extracts significantly (p < 0.01) decreased the pain stimulus only in the later phase of the formalin test, suggesting that the drug could be peripherally acting. Yedapo (1996) investigated the phosphate buffered saline extract of the roots of P. zeylanica for antiinflammatory activity. The extract stabilized red blood cells subjected to both heat and hypotonic induced lyses. The extract exhibited a biphasic response. The enzymatic activities of both alkaline and acid phosphatases were reduced, while adenosine triphosphatase activity was stimulated in the liver homogenates of formaldehyde induced arthritic rats. Poosarla and Athota (2007) investigated the role of an ethyl acetate fraction of the root extract of P. zeylanica in its antiarthritic activity in collagen type II-induced arthritis in DBA/1 mice and in the suppression of humoral antibody and stimulation of T cell mediated responses. PZE-6 suppressed collagen type II-induced arthritis in DBA/1 mice in a dose-dependent manner. In addition, the treatment with P. zeylanica stimulated Con A induced Tcell proliferation to normal levels in arthritic mice. Reddy et al. (2002) Bopaiah and Pradhan (2001) studied the effects of a 50% ethanol extract of the root of P. zeylanica on locomotor behavior and central dopaminergic activity in rats. The results showed that the extract specifically enhanced the spontaneous ambulatory activity without inducing stereotypic behavior. The neurochemical estimations revealed elevated levels of DA and HVA in striatum compared with the control rats (p < 0.01).
Anti-fertility activity
Toxicity studies
Anti-inflammatory activity
Antiarthritic activity
Wound healing activity
Locomotorbehaviour and central dopaminergic activity
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Hyperlipidaemic activity Alpana (1996) studied effect of P. zeylanica in hyperlipidaemic rabbits and its modification by vitamin E. There was significant reduction in serum total cholesterol, LDL cholesterol and triglyceride levels. Marked reduction was observed with the formulation of P. zeylanica and vitamin E. The total cholesterol/HDL and LDL/HDL cholesterol ratios were found significantly (p<0.01) decreased. Giday et al. (2007) conducted a study in two sub-districts of the Shinasha, Agew-awi and Amhara peoples in northwest Ethiopia to compile and analyzed knowledge on the use of medicinal plants for treatment or prevention of human ailments by three socio-cultural groups, Large proportions of medicinal plants were found to have been used for the treatments of gastro-intestinal complaints (26%), skin diseases (24%) and malaria (22%).
Some other research
Relatively, higher numbers of informants agreed on the use of Zehneria scabra against malaria (13%). The species Croton macrostachyus, Cattleya aurea, Canephora hirsuta and P. zeylanica were found to have the highest diversity of medicinal applications. Sandur et al. (2010) investigated whether 5-hydroxy-2-methyl-1,4-naphthoquinone (plumbagin), an analogue of vitamin K, and isolated from chitrak (Plumbago zeylanica), Plumbagin significantly potentiated the apoptotic effects of thalidomide and bortezomib in MM cells. Overall, these results suggest that the plumbagin inhibits STAT3 activation pathway through the induction of SHP-1 and this may mediate the sensitization of STAT3 overexpressing cancers to chemotherapeutic agents. Olagunju et al. (1999) studied the effects of the ethanol extract of the root of P. zeylanica on key enzymes of glycolysis and other biochemical parameters in the rat. The results show that thigh muscle hexokinase, phosphofructokinase, pyruvate kinase and lactate dehydrogenase activities were significantly reduced (p < 0.05) by 12.07, 51.02, 24.32 and 25.16%, respectively in rats treated with the ethanol extract of P. zeylanica when compared with the controls.
Effect of P. zeylanica on key enzymes of glycolysis
Conclusion
P. zeylanicais is used for centuries in Ayurvedic medicine to increase longitivity and vitality. It is the most important medicinal plant extensively used in herbal formulations. It is chemically rich with its diverse content of active compounds, such as plumbazin, chitranone, zeylanone and many useful naphthaquinone constituents as a multipurpose medicinal agentwere present. In this study, we have reviewed literature pertaining to P. zeylanica and its botanical constituents as immunostimulatory, hepatoprotective, and hypolipidamic agents and P. zeylanica can exhibit varying degrees of therapeutic values in the treatment of fungal, malaria and bacterial infections including cancer. From review of article it can be said that plant act as a very good anticancer drug. Future research with respect to clinical study need to be carried out to explore its uses.
